Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Sciences (3)
- Alternative and Complementary Medicine (2)
- Cardiovascular Diseases (2)
- Diseases (2)
- Medical Specialties (2)
-
- Organic Chemicals (2)
- Pharmaceutical Preparations (2)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Biochemical Phenomena, Metabolism, and Nutrition (1)
- Clinical and Medical Social Work (1)
- Dietetics and Clinical Nutrition (1)
- Endocrinology, Diabetes, and Metabolism (1)
- Family Medicine (1)
- Hormones, Hormone Substitutes, and Hormone Antagonists (1)
- Lipids (1)
- Medical Nutrition (1)
- Medicinal and Pharmaceutical Chemistry (1)
- Mental Disorders (1)
- Mental and Social Health (1)
- Other Chemicals and Drugs (1)
- Other Medical Specialties (1)
- Other Psychiatry and Psychology (1)
- Pharmaceutics and Drug Design (1)
- Pharmacy and Pharmaceutical Sciences (1)
- Psychiatric and Mental Health (1)
- Psychiatry (1)
- Psychiatry and Psychology (1)
- Psychological Phenomena and Processes (1)
- Keyword
-
- Diabetes (2)
- Fucoxanthin (2)
- Health (2)
- Inflammation (2)
- Lipids (2)
-
- Obesity (2)
- Depression (1)
- Esketamine (1)
- Heart failure with reduced ejection fraction (1)
- Hormonal contraception (1)
- Hospitalization (1)
- Human (1)
- Ketamine (1)
- MADRS (1)
- Male (1)
- Montgomery-Asberg (1)
- Nestorone (1)
- Placebo (1)
- Randomized controlled trial (1)
- SGLT2 Inhibitors (1)
- Testosterone (1)
- Treatment-resistant depression (1)
- Publication Type
Articles 1 - 5 of 5
Full-Text Articles in Chemicals and Drugs
Breakthroughs In Hormonal Male Contraception, Alexander Patton, Seth Vann
Breakthroughs In Hormonal Male Contraception, Alexander Patton, Seth Vann
Physician Assistant Capstones, 2020-current
Objective: Assess the efficacy of a nestorone plus testosterone gel at suppressing progestin levels and spermatogenesis.
Design: Systematic literature review.
Methods: Searches were done in PubMed and Dartmouth library using the terms nestorone, randomized control trial, human, and male. Limits used while searching included published in the last 10 years, randomized control trials, and English.
Results: Using the search criteria the following three studies were found that met the inclusion/exclusion criteria of this study: Ilani et al, Zitzmann et al, and Anawalt et al. All three studies were found on PubMed and reference the Ilani et al study.
Conclusion: Nestorone …
Sglt2 Inhibitors In The Management Of Heart Failure With Reduced Ejection Fraction, Susannah Jackson, Meghan Mathis
Sglt2 Inhibitors In The Management Of Heart Failure With Reduced Ejection Fraction, Susannah Jackson, Meghan Mathis
Physician Assistant Capstones, 2020-current
Objective: to assess whether SGLT2 inhibitors significantly reduce the risk of hospitalization for heart failure (HAHF) and cardiovascular death in patients with heart failure with reduced ejection fraction (HFrEF). Design: systematic literature review. Methods: searches were conducted in PubMed with the terms "SGLT2 Inhibitors,” “heart failure with reduced ejection fraction (HFrEF),” and "hospitalization” and the following limits: publication within the last 5 years, clinical trials, meta-analyses, randomized control trials, humans, and English. These criteria determined the selected literature: randomized control trial (RCT), use of an SGLT2i compared to placebo, and outcomes including HAHF and/or cardiovascular related death. Results: DAPA-HF: 27% …
Ketamine As A Treatment Modality For Treatment-Resistant Depression, Tracy Wulff, Shen Cao
Ketamine As A Treatment Modality For Treatment-Resistant Depression, Tracy Wulff, Shen Cao
Physician Assistant Capstones, 2020-current
Many recent studies have demonstrated the ability of ketamine, an NMDA receptor antagonist, to produce antidepressant effects that may be effective in helping reduce treatment-resistant major depression. In particular, three double-blinded randomized control trials have been conducted to assess the viability and effectiveness of this medication for treatment. This systematic literature review will analyze these studies and determine if the overall research indicates that ketamine is useful in improving depression as measured by the Montgomery–Asberg Depression Rating Scale (MADRS)1.
Objective: Assess the effectiveness of IV Ketamine in reducing treatment-resistant major depressive disorder as measured by the Montgomery–Asberg …
Fucoxanthin: A Review Of Potential Benefits Relative To Human Health, Michael R. White
Fucoxanthin: A Review Of Potential Benefits Relative To Human Health, Michael R. White
Masters Theses, 2020-current
Fucoxanthin is a carotenoid sourced and extracted mainly from dark orange and brown seaweeds found in the pacific ocean, such as the wakame algae. The allenic bonds and unique oxygen groups give fucoxanthin its unique structure and are thought to be part of the reason fucoxanthin has unique physiological functions. Fucoxanthin has potentially numerous effects on the physiology of human health, ranging from skin health to metabolic health, which have been demonstrated in animal model research. The goal of this review is to examine current literature to discuss fucoxanthin’s potential application as a nutraceutical, treatment for obesity, type 2 diabetes, …
Fucoxanthin: A Review Of Potential Benefits Relative To Human Health, Michael R. White
Fucoxanthin: A Review Of Potential Benefits Relative To Human Health, Michael R. White
Masters Theses, 2020-current
Fucoxanthin is a carotenoid sourced and extracted mainly from dark orange and brown seaweeds found in the pacific ocean, such as the wakame algae. The allenic bonds and unique oxygen groups give fucoxanthin its unique structure and are thought to be part of the reason fucoxanthin has unique physiological functions. Fucoxanthin has potentially numerous effects on the physiology of human health, ranging from skin health to metabolic health, which have been demonstrated in animal model research. The goal of this review is to examine current literature to discuss fucoxanthin’s potential application as a nutraceutical, treatment for obesity, type 2 diabetes, …